➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
AstraZeneca
Mallinckrodt
Express Scripts
Johnson and Johnson
Moodys

Last Updated: May 29, 2020

DrugPatentWatch Database Preview

Aspirin; butalbital; caffeine; codeine phosphate - Generic Drug Details

» See Plans and Pricing

« Back to Dashboard

What are the generic sources for aspirin; butalbital; caffeine; codeine phosphate and what is the scope of patent protection?

Aspirin; butalbital; caffeine; codeine phosphate is the generic ingredient in two branded drugs marketed by Mayne Pharma Inc, Nexgen Pharma Inc, Stevens J, Vintage Pharms Llc, Watson Labs, and Allergan, and is included in six NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-two drug master file entries for aspirin; butalbital; caffeine; codeine phosphate. Seven suppliers are listed for this compound.

Summary for aspirin; butalbital; caffeine; codeine phosphate

US Patents and Regulatory Information for aspirin; butalbital; caffeine; codeine phosphate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Vintage Pharms Llc BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE aspirin; butalbital; caffeine; codeine phosphate CAPSULE;ORAL 075351-001 Mar 5, 1999 DISCN No No   Start Trial   Start Trial   Start Trial
Mayne Pharma Inc BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE aspirin; butalbital; caffeine; codeine phosphate CAPSULE;ORAL 203335-001 Oct 30, 2015 AB RX No No   Start Trial   Start Trial   Start Trial
Watson Labs BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE aspirin; butalbital; caffeine; codeine phosphate CAPSULE;ORAL 074359-001 Aug 31, 1995 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
AstraZeneca
Mallinckrodt
Express Scripts
Johnson and Johnson
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.